| Patents for C07H 11 - Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof (1,722) |
|---|
| 09/01/2005 | WO2005080490A1 A solution of metal-polymer chelate(s) and applications thereof |
| 09/01/2005 | US20050191689 Novel nucleic acid base pair |
| 08/18/2005 | WO2005075490A2 Synthesis of polysulfated uronic acid glycosides |
| 08/16/2005 | CA2094859C Anticonvulsant fructopyranose cyclic sulfites and sulfates |
| 08/10/2005 | CN1651448A New crystalline technology of fructose-1, 6-trisodium diphosphate |
| 08/10/2005 | CN1651447A Preparation method of isomalto loigosaccharide sulphate (IMOS) |
| 08/09/2005 | CA2098886C Low temperature process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-d-ribofuranosyl sulfonates |
| 08/04/2005 | WO2005070944A1 Phosphoramidate derivatives |
| 08/04/2005 | US20050169982 Topiramate sodium, topiramate lithium, topiramate potassium, or polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, and amorphous forms; seizures, obesity, neuropathic pain, affective disorders, tobacco cessation, chronic fatigue syndrome, drug addiction; highly soluble, bioavailability |
| 08/03/2005 | EP1558624A1 Continuous process for the preparation of fructopyranose sulfamate derivatives |
| 07/27/2005 | CN1646538A Topiramate salts and compositions comprising and methods of making and using the same |
| 07/13/2005 | CN1210285C Remedies |
| 07/07/2005 | WO2005061523A1 Glycosaminoglycan (gag) mimetics |
| 07/07/2005 | CA2551181A1 Glycosaminoglycan (gag) mimetics |
| 07/05/2005 | US6914138 Urea nucleosides as therapeutic and diagnostic agents |
| 07/05/2005 | CA2360677C Anticonvulsant derivatives useful in treating bulimia nervosa |
| 06/22/2005 | EP1544294A1 Nucleosides or nucleotides having novel unnatural bases and use thereof |
| 06/08/2005 | CN1205216C Safflower lyochrome rich in carthamin A, its preparing process, its preparation containing them and its medical usage |
| 06/02/2005 | US20050118118 Nontoxic immunostimulants similar in structure to the lipopolysaccharides of Neisseria meningitidis as sunscreen agents in cosmetics; age resistance |
| 06/01/2005 | CN1204141C Salts of D-fructose-1, 6-bis(dihydrogen phosphate) with organic amine and pharmaceutical compositions containing them |
| 05/26/2005 | WO2004104015A8 Mannose-6-phosphonate compounds for the treatment of inflammatory diseases |
| 05/19/2005 | US20050107331 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 05/06/2005 | WO2005040181A1 α-1-PHOSPHORYLATED-2-DEOXY-2-FLUOROARABINOSIDE AND PROCESS FOR PRODUCING 2'-DEOXY-2'-FLUORO-β-D-ARABINONUCLEOSIDE |
| 05/06/2005 | CA2542915A1 .alpha.-1-phosphorylated-2-deoxy-2-fluoroarabinoside and process for producing 2'-deoxy-2'-fluoro-.beta.-d-arabinonucleoside |
| 05/04/2005 | CN1200003C Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same |
| 04/28/2005 | WO2003086283A9 Metastasis modulating activity of highly sulfated oligosaccharides |
| 04/28/2005 | US20050090456 useful as a reagent for glycotechnology |
| 04/14/2005 | US20050080042 synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides and pentasaccharides for use in the preparation of synthetic heparinoids; Vascular thrombosis, cardiovascular disease |
| 04/13/2005 | EP1521762A2 Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor |
| 04/13/2005 | EP1521761A2 Treatment of congenital disorders of glycosylation (cdg) using mannose |
| 04/13/2005 | CN1606446A Method for preventing and treating communicable diseases and other diseases using monosaccharides and disaccharides |
| 04/13/2005 | CN1196482C Use of anticonvulsant derivatives for treating bulimia nervosa |
| 04/12/2005 | US6878690 Compounds and methods |
| 04/12/2005 | CA2362336C Anticonvulsant derivatives useful in treating essential tremor |
| 04/12/2005 | CA2131229C Bisconjugates comprising two saccharides and a spacer |
| 04/07/2005 | WO2004113289A3 Glycosidase inhibitors and methods of synthesizing same |
| 03/24/2005 | WO2004104015A3 Mannose-6-phosphonate compounds for the treatment of inflammatory diseases |
| 03/24/2005 | US20050065139 Antidiabetic agents; controlling carbohydrate metabolism |
| 03/17/2005 | US20050059817 Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivatives |
| 02/10/2005 | WO2005012319A1 Production of 2-18f-2-deoxy-d-glucose via solid-phase synthesis |
| 01/26/2005 | EP1248629B1 Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs |
| 01/20/2005 | WO2004089965A3 Topiramate and processes for the preparation thereof |
| 01/19/2005 | EP1496916A2 Metastasis modulating activity of highly sulfated oligosaccharides |
| 01/19/2005 | CN1568370A Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists |
| 01/13/2005 | US20050010044 Deblocking/deprotecting; sulfonation; glycosaminoglycans |
| 01/06/2005 | WO2005000907A1 Sulfo-protected polysaccharides and methods and intermediates useful for their preparation |
| 01/06/2005 | US20050004069 Antiinflammatory agents |
| 12/30/2004 | US20040267007 Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors and intermediates therefor |
| 12/29/2004 | WO2004113289A2 Glycosidase inhibitors and methods of synthesizing same |
| 12/29/2004 | CN1558911A Synthetic heparin pentasaccharides |
| 12/29/2004 | CA2534094A1 Glycosidase inhibitors and methods of synthesizing same |
| 12/23/2004 | US20040259840 Using phosphoglycerides, lipid having sphingosine base, glycerides and sterol; wound healing agents; atherosclerosis |
| 12/16/2004 | US20040254367 Cyclic tetrasaccharide for use in detergents, moisture-retaining agents, skin-care agents, foods, cosmetics and pharmaceuticals; synthesized by chemically reacting reagents with a cyclotetrasaccharide obtained by allowing enzymes to act on starch |
| 12/15/2004 | EP1485388A2 Topiramate salts and compositions comprising and methods of making and using the same |
| 12/14/2004 | CA2261597C Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same |
| 12/02/2004 | WO2004104015A2 Mannose-6-phosphonate compounds for the treatment of inflammatory diseases |
| 12/01/2004 | EP1480654A1 Carbohydrate-based anti-wrinkle and tissue remodelling compounds |
| 12/01/2004 | CN1551882A Novel anticonvulsant derivative salts |
| 12/01/2004 | CN1177855C Carbohydrate derivatives |
| 11/25/2004 | US20040236085 Solid-phase nucleophilic fluorination |
| 11/24/2004 | CN1176933C Magnesium zinc fructose diphosphate and its preparing process and application in preparing medicines |
| 11/24/2004 | CN1176932C Zinc fructose-diphosphate and its preparing process and application |
| 11/17/2004 | EP1477171A1 Intestinal mineral absorption capacity improver |
| 10/28/2004 | WO2004092192A1 Sulfoglycolipid antigens, their extraction from mycobacterium tuberculosis, and their use against tuberculosis |
| 10/27/2004 | CN1172944C Preparation of magnesium fructose-1,6-diphosphate |
| 10/21/2004 | WO2004089965A2 Topiramate and processes for the preparation thereof |
| 10/21/2004 | US20040208875 Method for treating amyloidosis |
| 10/20/2004 | EP1469007A1 Sulfoglycolipid antigens, their extraction from mycobacterieum tuberculosis, and their use against tuberculosis |
| 10/14/2004 | US20040202649 Identification of the MECA-79 antigen and related methods of treating L-selectin-mediated conditions |
| 10/13/2004 | EP1466969A1 Sulfated fucan |
| 10/07/2004 | US20040198697 Compositions for the regulation of cytokine activity |
| 10/07/2004 | US20040197289 Kind of oligosaccharides, their sulfates and dendrimers, and the uses of these compounds |
| 10/05/2004 | US6800613 Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds |
| 09/22/2004 | EP1460081A1 Sugar derivative |
| 09/22/2004 | EP1458733A1 Silver salts of sucrose-octasulphate |
| 09/22/2004 | CN1530368A Synthesis of sulfated alpha (1->3) linked L-fucose |
| 09/16/2004 | US20040180813 4-Amino acid functionalized-2-pyrophosphatyl-pyranes; direct assay, high throughput screening for enzyme inhibitors; N-acetylglucosaminyltransferase |
| 09/01/2004 | CN1164603C 1,6-fructostrontium biphosphate compounds and their preparing process and medical application |
| 08/31/2004 | CA2098076C Imidate prodrugs of pharmaceutically useful anticonvulsant sulfamates |
| 08/26/2004 | WO2003086283A3 Metastasis modulating activity of highly sulfated oligosaccharides |
| 08/25/2004 | CN1524085A Oligose ,sulfating product and oligose cluster and its uses |
| 08/24/2004 | US6780849 Nitric-oxide releasing lipid molecules selected from phosphoglycerides, lipids having a sphingosine base as a backbone, a monoglyceride, a diglyceride, a glycosylacylglycerol and a sterol containing s-n=o, n-n=o or |
| 08/12/2004 | US20040158081 Continuous process for the preparation of fructopyranose sulfamate derivatives |
| 08/11/2004 | CN1520458A Sulfated fucoglucuronomannan |
| 08/11/2004 | CN1520315A Solid-phase nucleophilic fluorination |
| 08/11/2004 | CN1519245A Diabetin-1, 6-diphosphonie acid as well as preparation method and application |
| 08/10/2004 | CA2130124C Anomeric fluororibosyl amines |
| 07/29/2004 | WO2004063210A1 Novel anticonvulsant derivative salts |
| 07/29/2004 | WO2004062599A2 Certain aminoalkyl glucosaminide phosphate compounds and their use |
| 07/29/2004 | US20040147480 Prophylactic and therapeutic treatment of infectious and other diseases with mono-and disaccharide-based compounds |
| 07/29/2004 | CA2512108A1 Certain aminoalkyl glucosaminide phosphate compounds and their use |
| 07/29/2004 | CA2511682A1 Novel anticonvulsant derivative salts |
| 07/28/2004 | EP1440077A1 Synthetic heparin pentasaccharides |
| 06/30/2004 | CN1155701C Fucoidan and microbial used in mufacturing sugar compound |
| 06/23/2004 | EP1429787A1 Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder |
| 06/15/2004 | US6750207 Compositions for the regulation of cytokine activity |
| 05/26/2004 | EP1421091A1 Saccharide sulfation methods |
| 05/21/2004 | WO2004041836A1 Continuous process for the preparation of fructopyranose sulfamate derivatives |
| 05/21/2004 | CA2504039A1 Continuous process for the preparation of fructopyranose sulfamate derivatives |
| 05/19/2004 | EP1418950A1 Solid-phase nucleophilic fluorination |